---
title: 'Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after
  prior systemic therapy: A global, observational study'
date: '2023-10-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37889520/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231027180837&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: In this observational study, AB emerges as a safe and efficacious
  treatment option in patients with HCC previously treated with other systemic ...'
disable_comments: true
---
CONCLUSION: In this observational study, AB emerges as a safe and efficacious treatment option in patients with HCC previously treated with other systemic ...